bergenin has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, Z; Cui, Y; Li, X; Liang, J; Ma, L; Ruan, H; Wang, Y; Wei, Y; Yang, C; Zhang, L; Zhou, B; Zhou, H | 1 |
1 other study(ies) available for bergenin and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Bergenin attenuates bleomycin-induced pulmonary fibrosis in mice via inhibiting TGF-β1 signaling pathway.
Topics: Animals; Benzopyrans; Bleomycin; Fibroblasts; Idiopathic Pulmonary Fibrosis; Lung; Mice; Mice, Inbred C57BL; Signal Transduction; Transforming Growth Factor beta1 | 2021 |